Disease or cure?

摘要

It Is a social good and a financial disaster. An era of remarkable medical breakthroughs has coincided with a period of collapsing returns from listed pharmaceutical firms and from venture-capital funds investing in medical research. The share prices of firms such as Pfizer and Merck trade at half their levels in 2000; venture funding has all but evaporated.